Sodium Hydroxide → HCID 59738184, compound
Reaction equation
[Br:1][C:2]1[CH:30]=[CH:29][C:28]([F:31])=[CH:27][C:3]=1[O:4][CH:5]1[CH2:10][CH2:9][N:8]([C:11]2[N:15]=[C:14]([C:16]3[CH:17]=[N:18][N:19]([CH2:21][C:22]([O:24]CC)=[O:23])[CH:20]=3)[O:13][N:12]=2)[CH2:7][CH2:6]1.[OH-].[Na+]>>[Br:1][C:2]1[CH:30]=[CH:29][C:28]([F:31])=[CH:27][C:3]=1[O:4][CH:5]1[CH2:10][CH2:9][N:8]([C:11]2[N:15]=[C:14]([C:16]3[CH:17]=[N:18][N:19]([CH2:21][C:22]([OH:24])=[O:23])[CH:20]=3)[O:13][N:12]=2)[CH2:7][CH2:6]1Participants
3
Procedure
The title compound was prepared in a similar manner as described in Example 7 (step 5) from ethyl (4-{3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-1-yl)acetate and aqueous NaOH.
Sources & evidence
- ORD record
- ord-fca4263f4b8d44eb9b822f917e22d96a
- Source dataset
- uspto-grants-2011_11
- Patent number
- US08063224B2
Reaction notes
Loading…